Written question asked by Lord Morris of Manchester (Labour), in the House of Lords. It was due for an answer on Thursday, 7 November 2002. It was answered by Lord Hunt of Kings Heath (Labour) on Thursday, 7 November 2002.
Hunt of Kings Heath, Lord
- Question
- Further to the Written Answer by Lord Hunt of Kings Heath on 9 October 2002 (639 c26WA), whether the National Health Service policy in England for the treatment of chronic hepatitis C is different from that in Scotland since 2000 in respect of positive appraisal guidance, access to recombinant blood products and addressing the compensation of patients infected with contaminated National Health Service blood products; and, if so, why. [HL 6297].
Secondary information
- Type
- Written question
- Reference
- 640 c149-50WA; HL 6297
- Session
- 2001-02
- Subjects
- Access Compensation Contamination Blood England Haemophilia Hepatitis NHS Medical treatments Patients Scotland Blood transfusions
Librarians' tools
- Timestamp
- 2022-06-01 12:30:08 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_750412
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_750412
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_750412